Parker Family Foundation
This organization is a private foundation dedicated to supporting a variety of causes, primarily focusing on health, education, and the arts. It demonstrates a strong commitment to Alzheimer's disease and related disorders, as evidenced by significant funding to relevant organizations. Additionally, it supports arts and culture nonprofits, educational initiatives, and international relief efforts, reflecting a broad commitment to enhancing community well-being. The foundation primarily serves organizations located in Massachusetts, with some support extending to entities in New York and Washington, D.C.
Source: Zeffy Agent · Mar 2026
Ideal Applicant
Established nonprofits with a visible Massachusetts presence or reputation in arts, education, Alzheimer’s/health causes, or occasionally national relief organizations seeking general operating support in the grant-size range observed.
Good Fit
- • Clear program presence or operations in Massachusetts.
- • Work in arts, education, Alzheimer’s/health, or established national relief work.
- • Capacity to receive multi-year or unrestricted/general operating support.
- • Existing relationships or introductions to trustees, advisors, or local intermediaries.
Geography
Giving is regionally concentrated: the latest year shows grants across three states but roughly 84% of dollars went to organizations in Massachusetts, indicating a state-focused footprint with some out-of-state recipients.
Recipient Variety
The foundation funded about 11–12 distinct recipients each year with a mix of arts, education, health, and occasional national relief groups; despite financial concentration in the top five, the roster of independent grantees is broad for the foundation's size.
New Applicants
The foundation added five new recipients in the latest year, showing it does admit unfamiliar grantees, but it also declares it funds only preselected applicants and has no public submission route, so direct access for an unsolicited applicant appears limited.
Source: Zeffy Agent · Mar 2026
